Study Confirms Increased CVT With AstraZeneca COVID Vaccine Study Confirms Increased CVT With AstraZeneca COVID Vaccine
Rates of cerebral venous thrombosis and thrombocytopenia were higher in patients who received the AstraZeneca COVID-19 vaccine in three Nordic countries.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 1, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Tunneled dialysis line-associated hemorrhagic shock following self-inflicted trauma in a hemodialysis patient: a case report - Bogdan L, Malavade T.
Complications of tunneled central venous catheters (CVCs) for hemodialysis are frequent, and most commonly include bacteremia, thrombosis, and stenosis. While bleeding is a relatively rare complication of dialysis lines overall, tunneled CVCs may present a... (Source: SafetyLit)
Source: SafetyLit - June 27, 2022 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news
Blood clot: The sign 'you may feel only when standing or walking'
THE NHS says blood clots can be very serious and need to be treated quickly. Blood clots are gel-like clumps of blood. A blood clot, or thrombus, can move through the bloodstream until it gets stuck in a narrow passageway and can sometimes be life threatening if not treated quickly. (Source: Daily Express - Health)
Source: Daily Express - Health - June 24, 2022 Category: Consumer Health News Source Type: news
COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT) [NG200], NICE ( updated 22nd June 2022)
This guideline covers vaccine-induced immune thrombocytopenia and thrombosis (VITT), a syndrome which has been reported in rare cases after COVID-19 vaccination. VITT may also be called vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) or thrombotic thrombocytopenic syndrome (TTS). Because VITT is a new condition, there is limited evidence available to inform clinical management, identification and management of the condition is evolving quickly as the case definition becomes clearer. This guideline was produced to support clinicians to diagnose and manage this newly recognised syndrome.
NICE is continually mo...
Source: Current Awareness Service for Health (CASH) - June 23, 2022 Category: Consumer Health News Source Type: news
Relative Risk for CVT Up After AZD1222 COVID-19 Vaccine
TUESDAY, June 14, 2022 -- The relative rates of hospital contacts for coagulation disorder and cerebrovascular disease are increased after AZD1222 COVID-19 vaccination, particularly for thrombocytopenia and cerebral venous thrombosis, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2022 Category: Pharmaceuticals Source Type: news
Metformin Use and VTE Risk in Adults With Type 2 Diabetes Metformin Use and VTE Risk in Adults With Type 2 Diabetes
Might metformin use reduce the risk of venous thromboembolism in patients with type 2 diabetes mellitus?American Journal of Epidemiology (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 14, 2022 Category: Intensive Care Tags: Internal Medicine Journal Article Source Type: news
A New Treatment of Choice for Basilar Thrombosis A New Treatment of Choice for Basilar Thrombosis
Dr Christoph Diener summarizes the best data from May ' s European Stroke Organisation Conference.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 13, 2022 Category: Consumer Health News Tags: Neurology & Neurosurgery Commentary Source Type: news
Managing Recurrent VTE Over the Long Term Managing Recurrent VTE Over the Long Term
Learning Objectives: a. Understand the differences in CV disease clinical presentations and their potential clinical outcomes between men and women b. Apply coordinated treatment for NVAF and VTE according to the latest guidelines and apply treatment tailored to the individual patient c. Identify thrombosis-associated disease, know when to treat and when to refer for specialist care or to the EDMedscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 13, 2022 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news
Is Thrombosis the Same as Deep Vein Thrombosis?
Title: Is Thrombosis the Same as Deep Vein Thrombosis?Category: Diseases and ConditionsCreated: 6/9/2022 12:00:00 AMLast Editorial Review: 6/9/2022 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 9, 2022 Category: Cardiology Source Type: news
Can You Survive Deep Vein Thrombosis?
Title: Can You Survive Deep Vein Thrombosis?Category: Diseases and ConditionsCreated: 6/2/2022 12:00:00 AMLast Editorial Review: 6/2/2022 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 2, 2022 Category: Cardiology Source Type: news
Risk for VTE Up During Five Years After Prostate Cancer Diagnosis
TUESDAY, May 24, 2022 -- Men with prostate cancer have an increased risk for venous thromboembolism (VTE) during the five years after cancer diagnosis, according to a study published online May 23 in BMJ Open.
Yanina Balabanova, from Bayer AG in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 24, 2022 Category: Pharmaceuticals Source Type: news
New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news
Blood clots: The habit which 'raises the risk of unwanted blood clots' - risk factors
UNWANTED blood clots can be very dangerous, and certain activities will put people at higher risk. A blood clot, or thrombus, can move through the bloodstream until it gets stuck in a narrow passageway and can sometimes be life threatening if not treated quickly. (Source: Daily Express - Health)
Source: Daily Express - Health - May 20, 2022 Category: Consumer Health News Source Type: news
Prevalence and Risk Factors for Preoperative Deep Venous Thrombosis in Pelvic and Acetabular Fractures
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - May 18, 2022 Category: Orthopaedics Tags: CME Article Source Type: news
Cancer: Four sensations in the leg could be among ‘first clues’ signalling 'lethal' cancer
THE ILL-DEFINED nature of cancer symptoms can significantly delay referrals, so keeping well-informed of warning signs is crucial. According to recent findings, however, up to 70 percent of cancer patients are unaware of having an increased risk of blood clots. What's more, deep vein thrombosis is sometimes the first clue of pancreatic cancer, which is notoriously difficult to treat. (Source: Daily Express - Health)
Source: Daily Express - Health - May 17, 2022 Category: Consumer Health News Source Type: news
